Skip to main content

Dental Radiography Market is Anticipated to Grow Witnessing a Steady CAGR during the Forecast 2022-2031


 

The global dental radiography market is projected to witness significant growth during the forecast period 2022–2031. The high prevalence and growing incidences of oral cancer, oral disorders and the technological advancements in dental radiography systems are the key propellers for the growth of the market. The development of advancements such as integration of software with the dental imaging systems, surge in dental tourism and increased awareness regarding dental care and oral hygiene are leading to the evolving of dental radiography continuously. In terms of regional markets potential, Europe and Asia-Pacific are projected to grow with considerable CAGR during the forecast period 2022–2031. The rising prevalence of oral disorders and oral cancer, rising need for cosmetic dentistry, growing technology adoption, and improving healthcare infrastructure are the macro factors that will advance the regions’ market growth.

The global dental radiography market report highlights that the market was valued at $2,328.5 million in 2021 and is expected to reach $3,914.8 million by the end of 2031. The market is expected to grow at a CAGR of 5.17% during the forecast period 2022–2031.

Global Dental Radiography Market Drivers

The high prevalence and growing incidences of oral diseases are one of the major factors augmenting the global dental radiography market.  Furthermore, dental radiography imaging systems are witnessing a better field of view in recent years. Extended fields of view are essential for panoramic radiographic imaging to analyze the anatomy of teeth, structural changes in mandible or maxilla, and surrounding soft tissues. The newly launched products in the global dental radiography market encompass necessary features that are required by dentists to carry out basic clinical functions as well as advanced surgical applications. As a result, the growth of oral diagnosis propels the global market for dental radiography.

Global Dental Radiography Market Restraints

The factors restraining the growth of the global dental radiography market include the risks associated with radiation exposure and delay in regulatory approvals. Exposure to ionizing radiations hinders the market's growth. Moreover, another factor restraining the growth of the global dental radiography market is the high cost associated with dental procedures and equipment.

Global Dental Radiography Market Opportunities

High growth opportunities in emerging economies and the emergence of local companies in Asia-Pacific and the Middle East and Africa hold immense potential for the global dental radiography market growth. In an era of software and digitalization, increased demand for cosmetic dentistry aids in rising the global market for dental radiography.

How This Report Can Add Value

Comments

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

  The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global  ligase market  is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development.   Impact Several techniques are employed in ...

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

  PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market   are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...